We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Gene Therapy Treatment Uses Microparticles to Deliver DNA or RNA

By LabMedica International staff writers
Posted on 18 Dec 2018
A novel gene therapy approach for correcting hereditary blood disorders is based on the use of megakaryocytic microparticles (MkMPs) to deliver plasmid DNAs and small RNAs to hematopoietic stem and progenitor cells (HSPCs).

HSPCs are important target cells for gene therapy applications. More...
However, currently genetic modifications of HSPCs rely on viral vectors, which is a delivery method with considerable risk of side effects to the patient.

To replace the viral delivery method, investigators at the University of Delaware (Newark, USA) developed a system based on megakaryocytic microparticles (MPs) for targeted delivery of plasmid DNA (pDNA) and small RNAs to HSPCs. Megakaryocytes (Mks) are large polyploidy cells derived from HSPCs upon thrombopoietin (Tpo) stimulation, which, upon maturation and fragmentation, give rise to circulating platelets, as well as to MkMPs, which are the most abundant MPs in circulation. The investigators had shown previously that, in vitro, Mks also shed MkMPs. They had also demonstrated that, in vitro, MkMPs specifically targeted and were taken up by human HSPCs through fusion and/or endocytosis following specific receptor recognition.

The investigators reported in the November 7, 2018, online edition of the journal Science Advances that with an optimized electroporation protocol, an average of 4200 plasmid copies per MP could be loaded into MP, thus enabling effective delivery of green fluorescent protein (GFP)-encoding pDNA to HSPCs and HSPC nuclei, with up to 81% nuclei containing pDNA. Effective functional small interfering RNA (siRNA) and microRNA (miRNA) delivery were also demonstrated.

The investigators also found that human MkMPs could target mouse HSPCs in vivo to induce de novo platelet biogenesis in a simple murine model, thus demonstrating in vivo target specificity and efficacy even when using a cross-species model. Furthermore, patient-specific or generic megakaryocytic MPs could be readily generated and stored frozen, which suggests that this system has great potential for therapeutic applications targeting HSPCs.

"A lot of researchers are trying to deliver DNA, nucleic acids, or drugs to target hematopoietic stem cells," said senior author Dr. Eleftherios T. Papoutsakis, professor of chemical and biomolecular engineering at the University of Delaware. "This is the right cell to target because it gives rise to all blood cells."

Related Links:
University of Delaware


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Toxoplasma Gondii Test
Toxo IgG ELISA
New
Shaking Incubator
Corning LSE 71L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New automated lab procedures can detect opioids in tiny amounts of blood (Photo courtesy of Tripathi Lab/Brown University)

First-Of-Its-Kind Quantitative Method Assesses Opioid Exposure in Newborns

As the opioid crisis continues to impact communities across the United States, laboratories encounter significant difficulties in accurately detecting opioid substances in individuals with opioid use disorder.... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: T cell immunity could be a marker for early Parkinson’s treatment (Photo courtesy of Shutterstock)

T Cells in Blood Can Detect Parkinson's Years Before Diagnosis

Diagnosing Parkinson’s disease before the appearance of motor symptoms remains one of neurology’s most significant challenges. Patients can go years—even decades—without a diagnosis, as subtle early indicators... Read more

Microbiology

view channel
Image: A prototype of the lateral flow test (Photo courtesy of University of Exeter)

POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques

Diagnosing mucormycosis—an aggressive and often deadly fungal infection—remains a major challenge due to the disease’s rapid progression and the lack of fast, accurate diagnostic tools. The problem became... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.